Skip to content

Efficacy and Cost: Benefit Ratio of 0, 1, and 2 Medial Branch Blocks for Lumbar Facet Joint Radiofrequency Denervation

Prospective Randomized Study Comparing 0, 1, and 2 Diagnostic Lumbar Medial Branch (Facet Joint) Blocks Before Radiofrequency Denervation in Patients With Chronic Low Back Pain: A Cost: Benefit Analysis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00484159
Enrollment
151
Registered
2007-06-08
Start date
2007-02-28
Completion date
2009-01-31
Last updated
2011-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Low back pain of suspected lumbar zygapophysial etiology

Brief summary

Lumbar zygapophysial (facet) joint pain is a common cause of low back pain. Radiofrequency (RF) denervation is an effective and low risk treatment of chronic low back pain of suspected facet joint etiology. Blocks of the medial branches innervating the joints are commonly used to localize the pain and make the diagnosis of facet joint pain. There is currently no standard number of diagnostic blocks: zero, one, and two blocks have all been utilized. Considering the high false positive and false negative rates of these blocks, the cost: benefit ratio has been questioned. No study to date has examined the practice of diagnostic medial branch blocks before RF denervation. The purpose of this study is to determine the optimal number of blocks before radiofrequency denervation. Three groups of patients will be studied. In group I, patients will undergo RF denervation based on history and physical exam alone. In group II, patients will undergo RF denervation based on a positive response to a single diagnostic block with local anesthetic. In group III, patients will undergo RF treatment only after a positive screening block and a positive confirmatory block.

Detailed description

Lumbar zygapophysial (facet) joints are recognized as one of the most common causes of chronic low back pain with an estimated prevalence among patients with LBP ranging from 15% to 40%. Radiofrequency (RF) denervation of facet joints has been utilized as an effective treatment of chronic pain attributed to these joints. Blocks of the medial branches innervating the joints are commonly used to localize the pain and make a diagnosis of lumbar zygapophysial (l-z) joint pain. However, considering the high false-positive rates of these blocks (25-40%), the false-negative rates (8-10%), and the number of blocks necessary to make the diagnosis before treatment, the cost-effectiveness of performing these blocks and the benefit of exposing these patients to additional risks is under question. The risks of RF denervation are so low (equivalent to performing the diagnostic block), some have questioned whether or not any diagnostic facet blocks should be performed before RF lesioning. The purpose of the study is to determine the optimal number of diagnostic blocks that should be performed before radiofrequency denervation in patients with chronic lower back pain with suspected facet joint etiology. In this prospective randomized study, we will recruit 150 patients with suspected chronic (l-z) joint pain without neurological symptoms to undergo one of three treatment modalities. In group I, 50 patients will undergo RF denervation based on history and physical exam alone (what we advocate in a recent review article). In group II, 50 patients will receive a single diagnostic block with 0.5% bupivacaine. Those that obtain greater than 50% pain reduction will undergo RF denervation. In group III, 50 patients will receive a block with either 2% lidocaine or 0.5% bupivacaine. Those patients that obtain greater than 50% pain relief with the first block receive a second block with the other local anesthetic. Patients that obtain greater than 50% pain relief with the second block then undergo RF. Patients in any group that obtain less than 50% pain relief with any block exit the study.

Interventions

PROCEDURERadiofrequency denervation of medial branches

Radiofrequency of medial branches that innervate the lumbar facet joints

Diagnostic medial branch block with 0.5% bupivacaine. Blocking the nerves that innervate the facet joints with a long-acting local anesthetic.

Diagnostic medial branch block with 2% lidocaine. Blocking the nerves that innervate the facet joints with a short-acting local anesthetic.

Radiofrequency lumbar facet denervation without a diagnostic block

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Axial low back pain unresponsive to conservative treatment measures such as physical therapy, manual therapy and pharmacotherapy * Duration of pain greater than 6 months

Exclusion criteria

* Age younger than 18 years * Objective evidence (MRI or physical exam findings) of lumbosacral radiculopathy * Prior radiofrequency treatment * Significant spinal stenosis or spondylolisthesis * Previous back surgery * Uncorrected coagulopathy * Unstable medical or psychiatric condition * Pregnancy * Allergies to local anesthetic

Design outcomes

Primary

MeasureTime frameDescription
Cost Per Successful Procedure3-monthsTotal cost per effective treatment at 3-months. Successful procedure defined as greater or equal to 50% pain relief and satisfaction lasting at least 3 months.

Secondary

MeasureTime frameDescription
Successful Treatment3-months postprocedureGreater or equal to 50% pain relief plus procedural satisfaction lasting at least 3 months. What is being measured is the number of participants with a positive outcome.

Countries

United States

Participant flow

Recruitment details

151 patients with axial low back pain and suspected lumbar facet arthropathy were recruited from pain clinics at Johns Hopkins and Walter Reed between January 2007 and April 2009 for lumbar facet interventions.

Pre-assignment details

Subjects had to be candidate for facet blocks or radiofrequency denervation. They had to have no neurological symptoms, failed conservative treatment and not had spinal fusion.

Participants by arm

ArmCount
Double-block Group
Radiofrequency lumbar facet joint denervation only if positive response to 2 diagnostic facet blocks.
50
Single-block Group
Radiofrequency lumbar facet joint denervation if positive response to single facet joint block.
50
Radiofrequency Group
Radiofrequency lumbar facet denervation without a diagnostic facet block.
51
Total151

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up110

Baseline characteristics

CharacteristicDouble-block GroupSingle-block GroupRadiofrequency GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
6 Participants6 Participants6 Participants18 Participants
Age, Categorical
Between 18 and 65 years
44 Participants44 Participants45 Participants133 Participants
Sex: Female, Male
Female
23 Participants24 Participants20 Participants67 Participants
Sex: Female, Male
Male
27 Participants26 Participants31 Participants84 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 500 / 500 / 51
serious
Total, serious adverse events
0 / 500 / 500 / 51

Outcome results

Primary

Cost Per Successful Procedure

Total cost per effective treatment at 3-months. Successful procedure defined as greater or equal to 50% pain relief and satisfaction lasting at least 3 months.

Time frame: 3-months

ArmMeasureValue (NUMBER)
Double-block GroupCost Per Successful Procedure15,241 U.S. dollars
Single-block GroupCost Per Successful Procedure17,142 U.S. dollars
Radiofrequency GroupCost Per Successful Procedure6286 U.S. dollars
Secondary

Successful Treatment

Greater or equal to 50% pain relief plus procedural satisfaction lasting at least 3 months. What is being measured is the number of participants with a positive outcome.

Time frame: 3-months postprocedure

ArmMeasureValue (NUMBER)
Double-block GroupSuccessful Treatment9 participants
Single-block GroupSuccessful Treatment7 participants
Radiofrequency GroupSuccessful Treatment17 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026